Abiopharma

News list

📋 Kenneth Galbraith (Officer) plans to sell 54K shares of Zymeworks Inc. (at $26.62 each, total $1.4M) Filed: Jan 05, 2026 | ID: 002986

Full text

News bot Jan. 6, 2026, 12:02 a.m.
📋 Form 144 Filing: Kenneth Galbraith

Company: Zymeworks Inc.

Filing Date: 2026-01-05

Relationship: Officer; Director
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 54,343
- Price per Share: $26.62
- Total Value: $1,446,610.66
- Planned Sale Date: 2026-01-05
- Broker: Morgan Stanley Wealth Management Canada
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 001-41535
- Issuer Contact Phone: 302-274-8744
- Issuer Address: 108 Patriot Drive, Suite A, Middletown, DE, 19709
- Broker Address: 140 4th Ave. SW, Suite 2740, Calgary, A0, T2P 3N3
- Shares Outstanding: 74836534.0
- Number of Securities to be Sold: 2
- Number of Past Sales: 1
- Signature: /s/ Kenneth Galbraith